Prediction of residual disease using circulating DNA detection after potentiated radiotherapy for locally advanced head and neck cancer (NeckTAR): a study protocol for a prospective, multicentre trial

BACKGROUND: Sensitive and reproducible detection of residual disease after treatment is a major challenge for patients with locally advanced head and neck cancer. Indeed, the current imaging techniques are not always reliable enough to determine the presence of residual disease. The aim of the NeckT...

Descripción completa

Detalles Bibliográficos
Autores principales: Ginzac, Angeline, Ferreira, Marie-Céleste, Cayre, Anne, Bouvet, Clément, Biau, Julian, Molnar, Ioana, Saroul, Nicolas, Pham-Dang, Nathalie, Durando, Xavier, Bernadach, Maureen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Study Protocol
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10318756/
https://www.ncbi.nlm.nih.gov/pubmed/37400806
http://dx.doi.org/10.1186/s12885-023-11136-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10318756/
https://www.ncbi.nlm.nih.gov/pubmed/37400806
http://dx.doi.org/10.1186/s12885-023-11136-2

Ejemplares similares